Covid-19 Vaccine and Drug Sales, Once Booming, Plateau

Argentina Noticias Noticias

Covid-19 Vaccine and Drug Sales, Once Booming, Plateau
Argentina Últimas Noticias,Argentina Titulares
  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 53%

Merck and some other drugmakers that had been ringing up lofty Covid-19 sales are dialing back forecasts, a sign the pandemic market is shifting now that supplies are ample and many people are vaccinated.

Since the start of the Covid-19 pandemic in 2020, the scientific understanding of its transmission and prevention has evolved. WSJ’s Daniela Hernandez explains what strategies have worked for stemming the spread of the virus and which are outdated in 2022.

Illustration: Adele MorganThe gold rush for drugmakers making Covid-19 vaccines and treatments might be over, as demand plateaus, supplies turn ample andMerck & Co. and Johnson & Johnson are among the companies cutting sales expectations for pandemic products this year as they assess the outlook.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

WSJhealth /  🏆 413. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Pfizer Says Their COVID-19 Vaccine For Kids Under 5 Is 80% Effective Against OmicronPfizer Says Their COVID-19 Vaccine For Kids Under 5 Is 80% Effective Against OmicronPfizer said in preliminary findings in a subset of a clinical trial indicate that 3 doses of the vaccine are 80% effective in preventing symptomatic infection.
Leer más »

If Pfizer's data pans out, when will little kids get the COVID-19 vaccine?If Pfizer's data pans out, when will little kids get the COVID-19 vaccine?Pfizer plans to submit the new data to the Food and Drug Administration this week, bringing families with young children one step closer to a long-awaited vaccine.
Leer más »

AstraZeneca's Covid-19 Vaccine Gets EU Approval for Third DosesAstraZeneca's Covid-19 Vaccine Gets EU Approval for Third DosesBy Jaime Llinares Taboada AstraZeneca PLC said Monday that its Covid-19 vaccine has been granted approval in the European Union as a third dose booster for...
Leer más »

Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5A third pediatric dose of the Pfizer-BioNTech COVID-19 vaccine in children 6 months to under 5 years of age prompted a strong immune response, with a safety profile that was similar to placebo, the companies said:
Leer más »

3 Air Force cadets who refused COVID-19 vaccine won’t be commissioned3 Air Force cadets who refused COVID-19 vaccine won’t be commissionedThe U.S. Air Force Academy says three cadets who have refused the COVID-19 vaccine will not be commissioned as military officers but will graduate with bachelor’s degrees.
Leer más »

COVID-19 vaccine for kids under 5: Pfizer says 3 small doses offer strong protectionCOVID-19 vaccine for kids under 5: Pfizer says 3 small doses offer strong protectionPfizer says it plans to give the data to U.S. regulators later this week. The 18 million tots under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
Leer más »



Render Time: 2025-03-12 23:51:12